Cargando…

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY

Detalles Bibliográficos
Autores principales: Röth, Alexander, Berentsen, Sigbjørn, Barcellini, Wilma, D’sa, Shirley, Jilma, Bernd, Michel, Marc, Weitz, Ilene C, Yamaguchi, Masaki, Nishimura, Jun-Ichi, Vos, Josephine, Cid, Joan, Storek, Michael, Wong, Nancy, Yoo, Ronnie, Jayawardene, Deepthi, Kralova, Katarina, Wardęcki, Marek, Shafer, Frank, Lee, Michelle, Broome, Catherine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429917/
http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35
_version_ 1785090830803927040
author Röth, Alexander
Berentsen, Sigbjørn
Barcellini, Wilma
D’sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C
Yamaguchi, Masaki
Nishimura, Jun-Ichi
Vos, Josephine
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Jayawardene, Deepthi
Kralova, Katarina
Wardęcki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M
author_facet Röth, Alexander
Berentsen, Sigbjørn
Barcellini, Wilma
D’sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C
Yamaguchi, Masaki
Nishimura, Jun-Ichi
Vos, Josephine
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Jayawardene, Deepthi
Kralova, Katarina
Wardęcki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M
author_sort Röth, Alexander
collection PubMed
description
format Online
Article
Text
id pubmed-10429917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299172023-08-17 P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Kralova, Katarina Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429917/ http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Röth, Alexander
Berentsen, Sigbjørn
Barcellini, Wilma
D’sa, Shirley
Jilma, Bernd
Michel, Marc
Weitz, Ilene C
Yamaguchi, Masaki
Nishimura, Jun-Ichi
Vos, Josephine
Cid, Joan
Storek, Michael
Wong, Nancy
Yoo, Ronnie
Jayawardene, Deepthi
Kralova, Katarina
Wardęcki, Marek
Shafer, Frank
Lee, Michelle
Broome, Catherine M
P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title_full P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title_fullStr P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title_full_unstemmed P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title_short P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
title_sort p1469: inhibition of complement c1s with sutimlimab in patients with cold agglutinin disease (cad): results following 9-week off-treatment period (washout) in the phase 3 cadenza study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429917/
http://dx.doi.org/10.1097/01.HS9.0000972760.33312.35
work_keys_str_mv AT rothalexander p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT berentsensigbjørn p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT barcelliniwilma p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT dsashirley p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT jilmabernd p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT michelmarc p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT weitzilenec p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT yamaguchimasaki p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT nishimurajunichi p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT vosjosephine p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT cidjoan p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT storekmichael p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT wongnancy p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT yooronnie p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT jayawardenedeepthi p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT kralovakatarina p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT wardeckimarek p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT shaferfrank p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT leemichelle p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy
AT broomecatherinem p1469inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecadresultsfollowing9weekofftreatmentperiodwashoutinthephase3cadenzastudy